Solvay (SOLB) Q2 2026 earnings summary
Event summary combining transcript, slides, and related documents.
Q2 2026 earnings summary
29 Jul, 2026Executive summary
Q2 2026 underlying net sales were €1,031 million, down 7.4% organically year-over-year, mainly due to weak soda ash pricing and the Middle East conflict disrupting operations.
Underlying EBITDA fell 19.5% organically to €187 million, with margin at 18.1%, impacted by the Middle East conflict and absence of a €20 million one-off gain from Q2 2025.
Bicarbonate and electronic-grade peroxides performed well, while soda ash export markets faced persistent pricing pressure; Coatis showed sequential improvement.
Transformation and cost-saving initiatives delivered tangible safety improvements and €26 million in structural cost savings in Q2 2026.
Free cash flow for H1 2026 was €15 million, with Q2 at €-11 million; capex for H1 reached €141 million.
Financial highlights
Q2 2026 underlying net sales: €1,031 million (-7.4% organic yoy); EBITDA: €187 million (-19.5% organic yoy); EBITDA margin: 18.1%.
H1 2026 underlying net sales: €2,028 million (-8.0% organic yoy); EBITDA: €406 million (-14.7% organic yoy); net profit: €139 million (-29.2% yoy).
Free cash flow to shareholders in H1 2026 was €15 million; Q2 2026 was -€11 million due to seasonality and concentrated cash outflows.
Capex for H1 2026 was €141 million, focused on HSE, maintenance, and energy transition projects.
Net debt stood at €1.8 billion at end of June 2026, leverage ratio at 2.3x, temporarily higher due to dividend payment.
Outlook and guidance
Full-year 2026 guidance confirmed: underlying EBITDA expected between €770 million and €850 million, including €20 million negative currency impact and €40 million transformation expenses.
Free cash flow to shareholders expected to be at least €200 million (net of €90 million transformation expenses), with capex around €300 million.
Guidance assumes the Saudi peroxides plant restarts before end of Q3 2026.
Cumulative structural cost savings targeted at €300 million by end of 2026.
Temporary transformation expenses will continue to impact free cash flow through 2027.
Latest events from Solvay
- Q1 2026 sales and EBITDA declined, but margins and 2026 guidance remain resilient.SOLB
Q1 2026 - Strong 2025 results with robust cash flow, cost savings, and accelerated sustainability initiatives.SOLB
Roadshow presentation - 2025 delivered strong cash flow and margins; 2026 outlook cautious with EBITDA €770–850m.SOLB
Q4 2025 - Q3 sales and EBITDA fell 7%, but margins, cash flow, and guidance remained robust.SOLB
Q3 2025 - Sales and EBITDA declined amid soft demand, but margins and cash flow stayed resilient.SOLB
Q2 2025 - Q3 2024 delivered resilient sales and EBITDA, with guidance confirmed at the high end.SOLB
Q3 2024 - Sequential EBITDA and margin gains offset year-over-year declines, with guidance upgraded.SOLB
Q2 2024 - Q1 2025 sales and EBITDA fell, but margins held and 2025 guidance is reaffirmed.SOLB
Q1 2025 - 2024 saw resilient EBITDA, strong cost savings, and reaffirmed growth and sustainability targets.SOLB
Q4 2024